Health TrialsbyHealthPanel

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors

This is a Phase I trial to evaluate the safety, tolerability and efficacy of nectin-4 targeting antibody-drug conjugate (SBE303) in participants with advanced solid tumors

Participants needed: 149
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Samsung Bioepis Co., Ltd.Updated: Oct 1, 2026Locations: 7
Eligibility criteria

Histologically-confirmed, locally advanced (unresectable) or metastatic solid tu...

Have spinal cord compression or clinically active central nervous system metasta... [+4]

Read more
Status: Not yet recruiting

A Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of SB35 (Proposed Ixekizumab Biosimilar) to Taltz in Healthy Participants

This is a randomised, double-blind, two-arm, parallel group, single-dose study to compare the pharmacokinetics, safety, tolerability, and immunogenicity of ixekizumab (SB35 and Taltz) in healthy participants.

Participants needed: 174
Trial details
Phase: Phase 1Age: 19-55Biological sex: AllType: InterventionalSponsor: Samsung Bioepis Co., Ltd.Updated: Aug 27, 2026
Eligibility criteria

Healthy male or female, aged 19-55 years (inclusive) on the day of signing the i... [+9]

Have a history and/or current presence of clinically significant atopic allergy,... [+33]

Read more